Daily as of 3 Nov 16:00 ET
- Price
- above both $16.56 vs 50 $16.48 / 200 $15.66
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 26 Sep 2024 ยท projected 29 bars out
Aurinia Pharmaceuticals (AUPH) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA sits above the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 8 Sep 2026 | ๐จGolden | 4-hour | 16 bars out | โ |
| 4 Aug 2026 | ๐Death | 4-hour | 28 bars out | 3 bar cross test |
| 20 Apr 2026 | ๐จGolden | 4-hour | 28 bars out | Not tested |
| 3 Mar 2026 | ๐Death | 4-hour | 23 bars out | 4 bar cross test |
| week of 6 Oct 2025 | ๐จGolden moderate | weekly | 28 bars out | Not tested |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.